European Society of Cardiology (ESC) 2017

The largest gathering of cardiovascular professionals will take place in Barcelona, Spain, as the European Society of Cardiology meets August 26-30, 2017. Scientists and clinicians from around the world will provide scientific and educational sessions covering the entire scope of cardiovascular science. Sign up for our daily e-mail blasts on our registration page, and check back here during the conference for the full coverage.


Dr John Eikelboom on the Surprising Results of the COMPASS Trial
   |    ESC 2017
John Eikelboom, MD, of McMaster University discusses the 3 outcomes of the COMPASS trial that address the main concerns of patients.
Dr Simon Gibbs Outlines Monotherapy vs Combination Therapy in Pulmonary Hypertension
   |    ESC 2017
The majority of patients with pulmonary arterial hypertension, except for a few special circumstances, will begin treatment on combination therapy, instead of monotherapy, because combination therapy has been shown in trials to ahve better outcomes, explained Simon Gibbs, MD, Reader in Pulmonary Hypertension at the National Heart and Lung Institute, Imperial College London.
Dr Christi Deaton: Ask Cardiac Patients About Their Diet and Exercise
   |    ESC 2017
Healthcare providers can encourage cardiac patients to adhere to exercise and diet guidelines by asking how they are doing with recommendations and emphasizing the importance of following through, explained Christi Deaton, PhD, RN, FAHA, FESC, of the University of Cambridge.
Dr Steven Nissen on Which Patients Should Be Treated With PCSK9 Inhibitors
   |    ESC 2017
Two recent trials have demonstrate which types of patients are benefit the most from being treated with PCSK9 inhibitors, explained Steven Nissen, MD, of Cleveland Clinic.
Dr Jeanette Stingone on Lasting Cardiovascular Effects of Prenatal Exposure to Air Pollution
   |    ESC 2017
Researchers have known for years: what happens to mom in pregnancy affects the baby. That holds true with prenatal exposure to air pollution, which has lingering cardiovascular effects, such as birth defects and a higher risk of obesity, explained Jeanette Stingone, PhD, of Mount Sinai Health System.
Dr Christi Deaton on Promoting Better Self-Management for Patients With CVD
   |    ESC 2017
Patients can self-manage their cardiovascular disease and improve their quality of life by improving diet, being more physically active, taking medications as prescribed, and being partners in their care with their healthcare provider, said Christi Deaton, PhD, RN, FAHA, FESC, of the University of Cambridge.
Dr John Eikelboom: COMPASS' Rivaroxaban Plus Aspirin Will Become Standard for CAD, PAD
   |    ESC 2017
The rivaroxaban plus aspirin combination therapy to treat patients with stable coronary or peripheral artery disease showed such benefits in the COMPASS trial that it should become the standard of care, said John Eikelboom, MBBS, MSc, FRCPC, associate professor at McMaster University.
   |    ESC 2017 > Laura Joszt
Patients with heart failure tend to have other health issues, requiring cardiologists to understand how to care for heart failure while keeping in mind treatment for these other comorbidities, said panelists at the European Society of Cardiology Congress 2017, held August 26-30 in Barcelona, Spain.
Adult ADHD Compendium
COPD Compendium
Dermatology Compendium
Diabetes Compendium
GI Compendium
Hematology Compendium
Immuno-oncology Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Pain Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
Managed Care PODCAST
Upcoming Partner Events
October 16-17, 2017
Washington, D.C.
October 24-25, 2017
San Francisco, CA